Bristol-Myers Squibb Company
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Bristol-Myers Squibb Company Company Information, Fundamentals, and Technical Indicators
BMY takes the fight against disease to the heart, with leading cardiovascular medications like Camzyos—an FDA-approved treatment for obstructive hypertrophic cardiomyopathy. The global biopharmaceutical company is also well-known for its development of oncology and immunology products, including Opdivo and Yervoy for cancer treatment, and Orencia for rheumatoid arthritis. If you are looking to add a well-diversified biopharmaceutical stock to your portfolio, BMY could be the one.
Bristol-Myers Squibb Company In Our Stock Scanner
As of Sep 04, 2025Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.